Long QT syndrome type 3
Clinical trials for Long QT syndrome type 3 explained in plain language.
Never miss a new study
Get alerted when new Long QT syndrome type 3 trials appear
Sign up with your email to follow new studies for Long QT syndrome type 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame dangerous heart rhythms in genetic disorder
Disease control Recruiting nowThis study tests whether the drug THRV-1268 can safely shorten the heart's electrical recovery time (QT interval) in people with Long QT Syndrome Type 2, a genetic condition that raises the risk of dangerous heart rhythms and sudden cardiac arrest. About 64 participants will take…
Matched conditions: LONG QT SYNDROME TYPE 3
Phase 2/3 • Sponsor: Thryv Therapeutics, Inc. • Aim: Disease control
Last updated Sep 21, 2026 22:00 UTC
-
Heart condition's hidden toll: new study asks patients about life quality
Knowledge-focused Recruiting nowThis study aims to understand how Long QT Syndrome types 2 and 3 affect the quality of life and daily burden of adults. Researchers will ask up to 200 participants to fill out questionnaires about their physical, emotional, and social well-being. No treatment is given; the goal i…
Matched conditions: LONG QT SYNDROME TYPE 3
Sponsor: Thryv Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC